Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W A Craig

Showing results (31-40 of 162) with videos related to

Pageof 17
Sort By:
Annals of Internal Medicine|June 1, 1987
The postantibiotic effectW A Craig, B Vogelman
Seminars in Respiratory Infections|January 22, 1998
Aminoglycosides are useful for severe respiratory tract infectionsW A Craig, D Andes
Antimicrobial Agents and Chemotherapy|November 26, 2003
Pharmacodynamics of the new des-f(6)-quinolone garenoxacin in a murine thigh infection modelD Andes, W A Craig
Infectious Disease Clinics of North America|January 15, 1999
Pharmacokinetics and pharmacodynamics of outpatient intravenous antimicrobial therapyD Andes, W A Craig
Antimicrobial Agents and Chemotherapy|December 27, 2005
Pharmacodynamics of a new streptogramin, XRP 2868, in murine thigh and lung infection modelsD Andes, W A Craig
Scandinavian Journal of Infectious Diseases. Supplementum|January 1, 1978
Changes in protein binding during diseaseW A Craig, B Suh
Antimicrobial Agents and Chemotherapy|March 30, 2006
Pharmacodynamics of a new cephalosporin, PPI-0903 (TAK-599), active against methicillin-resistant Staphylococcus aureus in murine thigh and lung infection models: identification of an in vivo pharmacokinetic-pharmacodynamic targetD Andes, W A Craig
International Journal of Antimicrobial Agents|April 30, 2002
Animal model pharmacokinetics and pharmacodynamics: a critical reviewD Andes, W A Craig
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 8, 2005
Treatment of infections with ESBL-producing organisms: pharmacokinetic and pharmacodynamic considerationsD Andes, W A Craig
The Journal of Pediatrics|May 1, 1986
Kinetics of antimicrobial activityB Vogelman, W A Craig
Pageof 17

Showing results (31-40 of 162) with videos related to

Sort By:
Pageof 17
Annals of Internal Medicine|June 1, 1987
The postantibiotic effectW A Craig, B Vogelman
Seminars in Respiratory Infections|January 22, 1998
Aminoglycosides are useful for severe respiratory tract infectionsW A Craig, D Andes
Antimicrobial Agents and Chemotherapy|November 26, 2003
Pharmacodynamics of the new des-f(6)-quinolone garenoxacin in a murine thigh infection modelD Andes, W A Craig
Infectious Disease Clinics of North America|January 15, 1999
Pharmacokinetics and pharmacodynamics of outpatient intravenous antimicrobial therapyD Andes, W A Craig
Antimicrobial Agents and Chemotherapy|December 27, 2005
Pharmacodynamics of a new streptogramin, XRP 2868, in murine thigh and lung infection modelsD Andes, W A Craig
Scandinavian Journal of Infectious Diseases. Supplementum|January 1, 1978
Changes in protein binding during diseaseW A Craig, B Suh
Antimicrobial Agents and Chemotherapy|March 30, 2006
Pharmacodynamics of a new cephalosporin, PPI-0903 (TAK-599), active against methicillin-resistant Staphylococcus aureus in murine thigh and lung infection models: identification of an in vivo pharmacokinetic-pharmacodynamic targetD Andes, W A Craig
International Journal of Antimicrobial Agents|April 30, 2002
Animal model pharmacokinetics and pharmacodynamics: a critical reviewD Andes, W A Craig
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 8, 2005
Treatment of infections with ESBL-producing organisms: pharmacokinetic and pharmacodynamic considerationsD Andes, W A Craig
The Journal of Pediatrics|May 1, 1986
Kinetics of antimicrobial activityB Vogelman, W A Craig
Pageof 17